Targeting lung cancer cells with MUC1 aptamer-functionalized PLA-PEG nanocarriers
Open Access
- 18 March 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-11
Abstract
MUC1 aptamer-functionalized PLA-PEG nanocarriers at various w/w ratios (polymer to doxorubicin weight ratio) were prepared by a double emulsion method. Physiochemical properties, encapsulation efficiency (EE), loading content (LC) and in vitro release kinetics of DOX were assessed. Furthermore, cytotoxicity and antitumor activity of prepared PLA-PEG-Apt/DOX NPs at w/w ratio 10:1 were evaluated by MTT assay and flow cytometry against MUC1-overexpressing A-549 cell line. Targeted nanocarriers (PLA-PEG-Apt/DOX NPs at w/w ratio 10:1) induced higher apoptosis rate (36.3 ± 3.44%) for 24 h in MUC1 positive A-549 cancer cells in compare to non-targeted form (PLA-PEG/DOX NPs at w/w ratio 10:1, 11.37 ± 1.65%) and free DOX (4.35 ± 0.81%). In other word, the percentage of cell death in A-549 lung cancer cells treated with PLA-PEG-Apt/DOX NPs at w/w ratio 10:1 is 3.19 and 8.34 fold higher than in non-targeted form and Free DOX treated cancer cells, respectively. Therefore, PLA-PEG-Apt/DOX NPs might be considered a promising drug delivery system for targeted drug delivery towards MUC1-overexpressing tumors cells.Keywords
This publication has 60 references indexed in Scilit:
- MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 deliveryInternational Journal of Pharmaceutics, 2014
- Synthesis and in vitro evaluation of a pH-sensitive PLA–PEG–folate based polymeric micelle for controlled delivery of docetaxelColloids and Surfaces B: Biointerfaces, 2014
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biologyAdvanced Drug Delivery Reviews, 2014
- Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cellsInternational Journal of Pharmaceutics, 2013
- Novel MUC1 Aptamer Selectively Delivers Cytotoxic Agent to Cancer Cells In VitroPLOS ONE, 2012
- Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicinColloids and Surfaces B: Biointerfaces, 2011
- Novel Aptamer-Nanoparticle Bioconjugates Enhances Delivery of Anticancer Drug to MUC1-Positive Cancer Cells In VitroPLOS ONE, 2011
- Targeting cancer cells with nucleic acid aptamersTrends in Biotechnology, 2010
- DNA Aptamers That Bind to MUC1 Tumour Marker: Design and Characterization of MUC1-Binding Single-Stranded DNA AptamersTumor Biology, 2006
- Nanoparticle-Aptamer BioconjugatesCancer Research, 2004